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Introduction  
Varicella Zoster Virus (VZV) is a double stranded DNA virus of a a-herpes virus family 
which also include herpes simplex virus type 1 and 2.1 VZV causes chicken pox 
(varicella) during primary infection, following which the virus establishes the latency in 
cells of the dorsal root ganglia. Reactivation of latent virus causes shingles (herpes 
zoster), a disease predominantly occurring in elderly or immunocompromised patients. 
National incidence rate of chicken pox in Pakistan is unknown. In United States, before 
the availability of varicella vaccine, varicella disease was responsible for an estimated 4 
million cases, 11,000 hospitalizations, and 100 deaths each year. 2 Approximately 90% 
of cases occur in children and rarely in adults. Fifty five percent of varicella-associated 
deaths occurred among persons aged greater than or equal to 20 years. 3 We report a fatal 
case of primary varicella in an immunocompetent adult with severe complications 
resulting in death. The case highlights the importance of vaccination in children as well 
as high risk adult population in our country. 
Case Report  
A 42 year old man presented with one week history of intennittent colicky abdominal 
pain, vomiting and jaundice. Two days prior to admission he developed vesicular skin 
rash over face, anns and chest. One day prior to admission he passed hard stools mixed 
with fresh blood. He was recently found to be positive for hepatitis B surface antigen. 
Four days prior to his illness; two of his children had a febrile illness with vesicular skin 
rash diagnosed as chickenpox. He was a fisherman by profession, occasionally drank 
small amount of alcohol and smoked 15 cigarettes daily for the last 30 years. On physical 
examination, he was jaundiced, had pedal edema and vesicular eruption allover the body 
particularly in axilla, chest and face (Figure I ). F ew of the vesicles were umblicated. He 
had conjunctival hemorrhage in both eyes. No lymphadenopathy was detected. Bilateral 
inspiratory crackles were heard at lung bases. Abdominal, cardiovascular and 
neurological examinations were unremarkable. Initial laboratory workup showed 
hemoglobin of 13.8 grams/dl, white blood cells 5.7/cmm and platelets were clumped, 
creatinine 0.9 mg/dl, total bilirubin 2 mg/dl, serum alanine aminotransferase 213, LDH 
was 2676 and lipase was 537. [(0)] CT scan of abdomen revealed nodularity in liver and 
mild ascites. There was moderate splenomegaly and varices noted along the splenic vein. 
Findings were suggestive of chronic liver disease with portal hypertension. Bilateral soft 
tissue infiltrates were noted in the lungs consistent with pneumonitis (Figure 2). A Tzank 
Smear of vesicular lesion from chest revealed inclusion bodies (Figure 3). Following 
admission, treatment was started with high dose intravenous acyclovir and meropenam. 
He required intubation the following day and his clinical condition continued to 
deteriorate with development of acute renal failure and disseminated intravascular 
coagulation. He started bleeding from the mouth, nose and endotracheal tube and did not 
respond to aggressive management and died on the 4th day of admission. 
Discussion  
Humans are infected with VZV by contact with respiratory mucosa or conjunctiva. The 
virus disseminates through the blood stream inside monocular cells and to the skin 
causing the generalized vesicular skin rash of varicella. 4 Primary varicella infection 
(chicken pox) is a common, highly contagious, vaccine preventable disease. Varicella is 
usually a self limited disease that lasts 4-5 days and is characterized by fever, malaise, 
and generalized vesicular rash typically consisting of 250-500 lesions.2 The average 
incubation period for varicella is 14 days and almost all cases occur 10-20 days after 
exposure. 5 In contrast, reactivation disease (herpes zoster) in immunocompetent 
individuals is usually a localized illness, affecting the skin innervated by one or two 
adjacent dermatomes. However, in patients with impaired cell mediated immunity 
disseminated disease with widespread cutaneous and visceral involvement may develop 6 
and may take the one of four forms: local (classic) zoster, atypical generalized zoster with 
or without visceral involvement, and visceral zoster without skin lesions. 7 Our case did 
not have previous history of chicken pox and had no obvious underlying cause for 
cellular immuno- deficiency disorders. His history and diagnostic work- up is suggestive 
of primary varicella infection (chicken pox). Anecdotal observations and case reports 
have previously noted that varicella occurs more frequently in adults in tropical than in 
temperate climates. 8 In general, adults with varicella are more severely ill than children 
and have a greater incidence of varicella pneumonia and death. 5 Previous analyses of 
age specific risks have estimated that the risk of death is 25 times more and the risk of 
developing encephalitis is eight times higher in adults than in children.8 In several series 
of hospitalized adults, primary varicella pneumonia has been observed in more than 14% 
ofpatients, 8 In our country, chicken pox in adults is suspected on clinical grounds and 
confirmed either by tzank smear or type specific serology. VZV can be recovered on 
culture of the vesicular fluid for a few days after onset of rash but specific laboratory 
facility for isolation of the virus are not commonly available in our country. Varicella 
(chicken pox) in adolescents and adults tends to be more severe, and should be treated 
promptly, preferably within 24 hours of the onset of rash. 5 IV acyclovir is the drug of 
choice. Newer formulation like valacyclovir or famciclovir could be used orally. 
Varicella can be prevented in a recently exposed unvaccinated or immunocompromised 
person by the administration of varicella-zoster immune globulin. It must be given within 
96 hours of exposure to be effective. 9 Our patient did not survive even with aggressive 
management and manifested multiple complications including pneumonitis, pancreatitis 
and disseminated intravascular coagulation. The reason for poor response was probably 
the delayed presentation to hospital which is a common problem in managing these cases 
in our country. This case highlights the importance of increasing public awareness, 
vaccination, early recognition and diagnosis by community physicians, and prompt 
treatment or referral to the hospital for management to prevent fatal complications. The 
vaccination of all children and susceptible adults should be considered and may decrease 
the incidence of this preventable disease. 
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